Articles dans des revues avec comité de lecture (61)
  1. 61. Snyers, L., Fontaine, V., & Content, J. (1989). Modulation of interleukin-6 receptors in human cells. Annals of the New York Academy of Sciences, 557, 388-395. doi:10.1111/j.1749-6632.1989.tb24031.x
    2.   Communications publiées lors de congrès ou colloques nationaux et internationaux (6)
  2. 1. Ravon, F., Menchi, E., Remmelink, M., Chraibi, S., Fontaine, V., & Wauthoz, N. (2022). In vitro and in vivo evaluations of the tolerance of a new and innovative anti-tuberculosis drug combination by inhalation. Abstracts from The Aerosol Society Drug Delivery to the Lungs 32. Vol. 35(35), A1-A20 (pp. 1-20) Drug Delivery to the Lungs(32: 8-10th December: Virtual). doi:10.1089/jamp.2022.ab01.abstracts
  3. 2. Fontaine, V., Boulenouar, S., Weyn, C., & Englert, Y. (2009). The trophoblast: a model to study HPV transcription, replication and host cell interactions. Retrovirology,(V6), 10.1186/1742-4690-6-S1-P1.
  4. 3. Fontaine, V., Mascaux, C., Bernis, A., Weyn, C., Celio, N., Kaufman, L., Garbar, C., & Content, J. (2007). Evaluation of combined general primers mediated PCR/sequencing and type-specific-PCR strategy for determination of human papillomavirus genotypes in cervical cell specimens. 23rd International Papillomavirus Conference & Clinical Workshop (2006: Prague)
  5. 4. Weyn, C., Jazouli, N., Bernis, A., & Fontaine, V. (2006). Regulation of the transcriptional activity of human papillomavirus type 16 LCR in choriocarcinoma cell lines. Association Belge pour l’Etude du Cancer (Antwerpen)
  6. 5. Brakenhoff, J. P., de Hon, F. D., Fontaine, V., Hart, E., De Groot, J., Content, J., & Aarden, L. A. (1992). Structure-function analysis oh human interleukin-6. Pathophysiology and pharmacology of cytokines (pp. 9-14).
  7. 6. Fontaine, V., de Wit, L., Brakenhoff, J. P., & Content, J. (1989). Structure-function studies on human interleukin-6. In Molecular and Cellular Biology of Cytokines (pp. 45-50) Wiley-Liss.
    8.   Participations à des congrès et colloques internationaux (20)
  8. 1. Ravon, F., Menchi, E., Remmelink, M., Chraibi, S., Fontaine, V., & Wauthoz, N. (2021). In vitro and in vivo evaluations of the tolerance of a new and innovative anti-tuberculosis drug combination by inhalation. Paper session presented at Drug Delivery to the Lung (32: 8-10th December 2021: Virtual).
  9. 2. Zeng, S., Constant, P., Yang, D., Baulard, A., Lefèvre, P., Daffé, M., Wattiez, R., & Fontaine, V. (2019). Cpn60.1 (GroEL1) contributes to mycobacterial Crabtree effect: implications for biofilm formation. Abstract session presented at Mycobactéries 2019(26-28/06/2019: Angers)
  10. 3. Anton Sales, C., Rojo Poveda, O., Oliveira Ribeiro, S., Fontaine, V., Keymeulen, F., Ngezahayo, J., Zeppa, G., & Stévigny, C. (2019). Unveiling Cocoa Bean Shell Antimicrobial Activity. Poster présenté à la conférence 4th Phytoday Congress (17/05/2019: Brussels (Belgium)).
  11. 4. Delporte, C., Souard, F., Ndedi Ekolo, F., Lognay, G. C., Van Antwerpen, P., Mathieu, F., Chasseur, C., & Fontaine, V. (2018). Targeted and untargeted metabolomics using LC-HRMS on cereal grains contaminated by fungi from endemic areas for Kashin-Beck Disease. Poster présenté à la conférence RFMF (23-25 mai 2018: Liège, Belgique).
  12. 5. Fontaine, V. (2017). Investigation of the role of GroEL-1 and PDIM in antibiotic resistance leads to repurpose drugs as antimycobacterial candidates. Paper session presented at Tuberculosis drug discovery & development Gordon Research Conference (25-30 juni 2017: Barga, Italy).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>